Trial Profile
Effects of rimonabant (Acomplia) on obesity in adults with Prader-Willi Syndrome.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2014
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 21 Jun 2011 New trial record